View in EDS PDF Full Text

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.

Saved in:
Bibliographic Details
Title: A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
Authors: Tsai, Max1, Chrones, Lambros1, Xie, Jinhui1, Gevorkyan, Hakop2, Macek, Thomas1 tom.macek@takeda.com
Source: Psychopharmacology. Oct2016, Vol. 233 Issue 21/22, p3787-3795.
Database: SPORTDiscus with Full Text
Description
ISSN:00333158
DOI:10.1007/s00213-016-4412-9